Skip to main content
Premium Trial:

Request an Annual Quote

Patrick Zenner, Alan Nies, Robert Friedman, Terri Lomax, Douglas Falkner, Larry Felser, John Tyson, John Guckenheimer, Christoph Lengauer, Mike Shuler

Premium

Patrick Zenner has joined the board of directors of Exact Sciences of Maynard, Mass., the applied genomics company said last week. Zenner was president and CEO of

Hoffman-LaRoche

before retiring in 2001. He is member of the board of directors for Curagen, Genta, Praecis Pharmaceuticals, and Xoma. Zenner holds an MBA from Fairleigh Dickinson University and a BS in business administration from Creighton University.

 

Alan Nies has joined the medical advisory board of Lexicon Genetics of The Woodlands, Texas, the company said last week. Nies is senior vice president, clinical sciences, at Merck. He holds an MD from Harvard Medical School and a BS from Stanford University.

 

Robert Friedman will become vice president for environment and energy policy at the Center for the Advancement of Genomics and the Institute for Biological Energy Alternatives. Friedman leaves the Heinz Center, where he was a vice president.

 

Terri Lomax, a professor of botany at Oregon State University, has been named director of NASA’s fundamental space biology division for a term to cover from two to four years. Lomax will keep her position at Oregon State, where she is director of the university’s program for the analysis of biotechnology issues.

 

Douglas Falkner has been named managing director of East Coast operations for Los Angeles-based Applied DNA Sciences and will be located in the company’s new office in Henderson, NC. Falkner holds an MBA from the University of Southern California.

 

Larry Felser has been named director of systems and software development for Gene Network Sciences of Ithaca, NY. The company expanded its scientific advisory board, adding: John Tyson, professor of molecular cell biology at Virginia Tech; John Guckenheimer, a Cornell mathematics professor; Christoph Lengauer, assistant professor of oncology at Johns Hopkins University; and Mike Shuler, a Cornell professor of chemical engineering.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.